SCHEMBL15524916

SCHEMBL15524916

CC(=O)Nc1ccc2c(c1)CCN2Cc1ccc(C(=O)Nc2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.64
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
ALOX5 P09917 5/20 0.60
EPHX2 P34913 4/20 0.60
BTK Q06187 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 2/20 0.54
TP53 P04637 3/20 0.53
MAPT P10636 3/20 0.53
GAA P10253 1/20 0.53
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
KCNT1 Q5JUK3 1/20 0.52
CACNA1B Q00975 1/20 0.51
APBA1 Q02410 1/20 0.51
ALDH1A1 P00352 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15524907 0.88 ALOX5 (0.57) TNFMEN1KMT2AALOX5EPHX2
SCHEMBL15524920 0.88 ALOX5 (0.70) TNFALOX5EPHX2KCNT1ALDH1A1
SCHEMBL15524909 0.85 HTT (0.56) TNFMEN1KMT2AALOX5EPHX2
SCHEMBL15524919 0.85 ALOX5 (0.58) TNFMEN1KMT2AALOX5EPHX2
SCHEMBL15524917 0.84 ALOX5 (0.57) TNFALOX5EPHX2TP53KCNT1
SCHEMBL3101011 0.84 ALOX5 (0.74) TNFMEN1KMT2AALOX5EPHX2
SCHEMBL15524902 0.83 ALOX5 (0.56) TNFMEN1KMT2AALOX5EPHX2
SCHEMBL15601405 0.83 ALOX5 (0.60) TNFALOX5EPHX2KCNT1
SCHEMBL8130170 0.82 ALDH1A1 (0.63) MEN1KMT2AALOX5EPHX2SMN1; SMN2
SCHEMBL31577274 0.82 ALOX5 (0.72) ALOX5EPHX2KCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9321750-B2 ROR modulators and their uses INNOV17 LLC (US) 2016-04-26 US disclosed
US-9321750-B2 ROR modulators and their uses INNOV17 LLC (US) 2016-04-26 US disclosed
US-9321750-B2 ROR modulators and their uses INNOV17 LLC (US) 2016-04-26 US disclosed
US-20150284366-A1 ROR MODULATORS AND THEIR USES INNOV17 LLC 2015-10-08 US disclosed
US-20150284366-A1 ROR MODULATORS AND THEIR USES INNOV17 LLC 2015-10-08 US disclosed
US-20150284366-A1 ROR MODULATORS AND THEIR USES INNOV17 LLC 2015-10-08 US disclosed
EP-2844247-A1 ROR MODULATORS AND THEIR USES Gaweco, Anderson (US) 2015-03-11 EP disclosed
WO-2013159095-A1 ROR MODULATORS AND THEIR USES GAWECO ANDERSON (US) 2013-10-24 WO disclosed
WO-2013159095-A1 ROR MODULATORS AND THEIR USES GAWECO ANDERSON (US) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284366-A1 ROR MODULATORS AND THEIR USES RORA, RORB, RORC TNF 3068/4885MEN1 3868/4885KMT2A 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.